Pivekimab Sunirine-pvzy

Pivekimab Sunirine-pvzy · PIVEKIMAB SUNIRINE 2 mg/2mg · Injection, Powder, Lyophilized, For Solution · Rentschler Biopharma SE

NDC 64538-0282-02 · 1 mg in 1 VIAL, GLASS · BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (bulk ingredient for human prescription compounding) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: —
TE code: —
Approval date: —
Patents / exclusivity: —

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Pivekimab Sunirine-pvzy (Injection, Powder, Lyophilized, For Solution)

Labeler	Strength	First seen	Last seen
AbbVie Inc.	PIVEKIMAB SUNIRINE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Rentschler Biopharma SE	PIVEKIMAB SUNIRINE 2 mg/2mg	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Pivekimab Sunirine-pvzy — NDC 64538-0282-02," retrieved September 3, 2026, https://drugdashboards.com/drug/64538028202.

Free to cite with attribution — see how the data is put together.